Cellistic is a Belgium-based CDMO specializing in iPSC-based cell therapy manufacturing, positioned as a global leader in allogeneic iPSC-derived cell therapy production. The company offers full-spectrum manufacturing services including cell line development, process development, GMP manufacturing platforms, ready-to-use iPSC lines, and proprietary gene-editing capabilities. Cellistic operates Europe's first facility dedicated exclusively to iPSC-based cell therapy development and manufacturing in Mont-Saint-Guibert, Belgium.
iPSC-based cell therapy manufacturing, allogeneic cell therapy, cell line development, gene editing, immune-oncology, regenerative medicine
1 site worldwide
No reviews available yet.
No documents available.